Friday, February 2, 2007
A Texas judge has dismissed a hormone replacement therapy case on the verge of trial, based on FDA preemption, according to this Bloomberg article in today's Asbury Park Press -- Cancer Suit Against Wyeth Dismissed:
Madison-based Wyeth said a judge dismissed a lawsuit brought by a woman who claimed she developed breast cancer as a result of using the company's menopause drug Prempro.
Judge Caroline E. Baker of Houston said the woman couldn't accuse Wyeth of failing to warn about risks associated with Prempro because drug labels are regulated by the U.S. Food and Drug Administration, according to a Wyeth statement. Wyeth lawyers have said the company did what the FDA told them to do.
The trial was scheduled to begin on Monday, Feb. 5.